Signaturefd LLC Has $74,000 Stock Position in National Research Co. (NASDAQ:NRC)

Signaturefd LLC grew its position in National Research Co. (NASDAQ:NRC) by 613.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,173 shares of the company’s stock after purchasing an additional 3,588 shares during the period. Signaturefd LLC’s holdings in National Research were worth $74,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC bought a new stake in National Research in the third quarter worth $3,158,000. Bank of New York Mellon Corp boosted its stake in shares of National Research by 88.5% during the 4th quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after acquiring an additional 101,957 shares in the last quarter. Algert Global LLC raised its stake in shares of National Research by 94.0% in the 3rd quarter. Algert Global LLC now owns 82,921 shares of the company’s stock valued at $1,896,000 after acquiring an additional 40,182 shares in the last quarter. Barclays PLC lifted its holdings in National Research by 65.6% in the 3rd quarter. Barclays PLC now owns 51,331 shares of the company’s stock worth $1,175,000 after purchasing an additional 20,331 shares during the last quarter. Finally, Proficio Capital Partners LLC bought a new stake in National Research during the fourth quarter worth approximately $283,000. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Trading Up 1.7 %

NASDAQ:NRC opened at $14.68 on Tuesday. The company’s 50 day moving average is $16.18 and its 200-day moving average is $18.24. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 12 month low of $13.74 and a 12 month high of $40.14. The firm has a market cap of $336.85 million, a price-to-earnings ratio of 13.98 and a beta of 0.47.

National Research (NASDAQ:NRC) last announced its earnings results on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 3.27%. National Research’s payout ratio is 45.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.